Skip to main content
SpringerLink
Log in

GlaxoSmithKline opens the door on clinical data sharing

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Moves to release more data from clinical trials could provide unprecedented opportunities to understand disease biology and drug effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Charlotte Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harrison, C. GlaxoSmithKline opens the door on clinical data sharing. Nat Rev Drug Discov 11, 891–892 (2012). https://doi.org/10.1038/nrd3907

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3907

  • Springer Nature Limited

This article is cited by

Search

Navigation